Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease.
Miyake T, Yoshida S, Furukawa S, Sakai T, Tada F, Senba H, Yamamoto S, Koizumi Y, Yoshida O, Hirooka M, Kumagi T, Niiya T, Miyaoka H, Masanori A, Matsuura B, Hiasa Y.
Miyake T, et al. Among authors: sakai t.
Open Med (Wars). 2018 Sep 14;13:402-409. doi: 10.1515/med-2018-0059. eCollection 2018.
Open Med (Wars). 2018.
PMID: 30234161
Free PMC article.